AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis

cafead

Administrator
Staff member
  • cafead   Jul 14, 2024 at 10:22: PM
via AbbVie has submitted regulatory applications to both the FDA and the European Medicines Agency for Rinvoq (upadacitinib) to treat adult patients with giant cell arteritis (GCA)

article source
 

<